Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 43)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
9-Feb-10New Constructs, LLCN/ACEPH: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10  View Abstract
9-Feb-10EconomicInvestorN/A"The Economy Matters" Report for CEPH: the economy's impact on CEPH's price and risk, featuring the powerful EconomicInvestor Star Rating6$15  View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettPlunkett's Health Care Technologies Overview 2010 (Summary)80$199  View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299  View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71$199  View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettHealth Care Industry Market Research and Competitive Analysis 2010730$299  View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettHealth Care Industry Trends, Statistics & Analysis 2010 (Summary)98$199  View Abstract
8-Feb-10Market EdgeN/AMarket Edge Equity Research Report4$10  View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (Global)144$169  View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (North America)100$169  View Abstract
Next 20

Brokerage Reports (Showing 1 to 4 of 4)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
1-Feb-10Collins Stewart LLCLouise ChenMepha Deal is Good For CEPH2$10  View Abstract
20-Jan-10Collins Stewart LLCLouise ChenFebruary 2010 Catalyst Calendar25$75  View Abstract
31-Dec-09First GlobalKavita Thomas, Devina MehraFirst Global reiterates Outperform on TEVA14$50  View Abstract
30-Mar-09First GlobalLe Grand FromagFirst Global's Le Grand Fromage: Eats shoots and leaves6$30  View Abstract

Independent Reports (Showing 1 to 10 of 39)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
9-Feb-10New Constructs, LLCN/ACEPH: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10View Abstract
9-Feb-10EconomicInvestorN/A"The Economy Matters" Report for CEPH: the economy's impact on CEPH's price and risk, featuring the powerful EconomicInvestor Star Rating6$15View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettPlunkett's Health Care Technologies Overview 2010 (Summary)80$199View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71$199View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettHealth Care Industry Market Research and Competitive Analysis 2010730$299View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettHealth Care Industry Trends, Statistics & Analysis 2010 (Summary)98$199View Abstract
8-Feb-10Market EdgeN/AMarket Edge Equity Research Report4$10View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (Global)144$169View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (North America)100$169View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.